Stay updated on CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome
Sign up to get notified when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.

Latest updates to the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page
- Check3 days agoChange DetectedThe Record History shows a new site revision: v3.3.4 replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.3.3 was added to the history. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded revision v3.3.2 and removed revision v3.2.0 from the Study Record History; this update reflects administrative version control rather than substantive changes to the trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe government funding/operating status banner was removed from the page. This change does not affect the study records or their presentation.SummaryDifference0.5%

- Check74 days agoChange DetectedThe two screenshots depict the same page content with only minor layout/visual adjustments; no study data or version history details appear to change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check103 days agoChange DetectedMajor change: version updated to v3.2.0 with a government-operating-status notice; previous version v3.1.0 removed. Interpreted as an update to page status and versioning.SummaryDifference10%

Stay in the know with updates to CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome
Enter your email address, and we'll notify you when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.